Altria quarterly earnings miss estimates as cigarette maker’s revenue falls

Altria quarterly earnings miss estimates as cigarette maker’s revenue falls


Altria Group signage is displayed on a monitor on the floor of the New York Stock Exchange.

Michael Nagle | Bloomberg | Getty Images

Cigarette maker Altria Group on Thursday reported third-quarter earnings that missed Wall Street estimates as its revenue fell.

Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: $1.28 adjusted vs. $1.30 expected.
  • Revenue: $5.41 billion vs. $5.59 billion expected.

Shares of Altria were down 2% in pre-market trading.

The maker of Marlboro cigarettes, which has been working to diversify its offerings as smoking rates decline in the U.S., also announced a strategic partnership with Japan Tobacco to develop smoke-free tobacco products ahead of its earnings release.

The move comes after Altria in July slashed the value of its $13 billion stake in troubled vaping company Juul to less than 5% of its original value amid a regulatory crackdown on the products. Although Altria retains a 35% stake in Juul, it exercised its option last month to be released from its non-compete obligations with the company.

“We are excited to begin a new partnership with JT Group, a leading international tobacco company,” said Billy Gifford, Altria’s chief executive officer. “We believe this relationship can accelerate harm reduction for adult smokers across the globe.”

Last week,  Altria also said that Philip Morris International had agreed to pay $2.7 billion for the exclusive right to sell IQOS smokeless tobacco heating devices in the United States.

For its third quarter, Altria reported revenue net of excise taxes of $5.41 billion, a decline of 2% from a year ago. Its net income was $224 million for the period, or 12 cents per share. Excluding one-time items, it said it earned $1.28 per share.

For 2022, the company also narrowed its earnings per share guidance to be in the range of $4.81 to $4.89, representing a growth of 4.5% to 6% from 2021.

It had previously forecast full-year adjusted diluted earnings per share in a range of $4.79 to $4.93.

This is breaking news. Check back for updates.



Source

Forgotten no more: Generation X is driving beauty sales
Business

Forgotten no more: Generation X is driving beauty sales

Ryan Mckeever | E+ | Getty Images Move over, Sephora kids. While younger generations have been buying beauty products in droves, data shows that a different generation holds more spending power: Generation X. Often dubbed the “forgotten generation,” Gen X spans those born between 1965 and 1980, according to Pew Research Center. Sandwiched between baby […]

Read More
FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More